Faktor Prediktor Ketercapaian Target Tekanan Darah Pasien Hipertensi di RS PKU Muhammadiyah Gamping

Hypertension is a disease that ranks third as the cause of death in Indonesia and Yogyakarta is in third place. Many factors that affect achieving blood pressure targets, such as age, comorbidities, gender, duration of hypertension, and antihypertensive drug regimens are significantly associated with increased blood pressure. The purpose of this study was to describe using antihypertensive drugs and risk factors for achieving blood pressure targets in outpatient hypertension patients at PKU Muhammadiyah Gamping Hospital, Yogyakarta. This research is a non-experimental research by designing analytical descriptive research. Data collection was carried out retrospectively from medical records of outpatient hypertension patients from January to July 2019. Data were collected by purposive sampling. The sample in this study was obtained as many as 103 patients. The data were analyzed descriptively to see the pattern of use of antihypertensive drugs and the percentage of achievement of blood pressure targets. The relationship between age, comorbidities, gender, duration of hypertension, and antihypertensive drug regimen with achieving blood pressure targets was analyzed using bivariate and multivariate analysis. Results Based on the study, it was found that 42% of patients had achieved the blood pressure target based on Joint National Committee (JNC) VIII. Patients who received antihypertensive monotherapy were 33% and antihypertensive combinations were 67%. The most common monotherapy was Calcium Chanel Blocker (17.48%) while the most common antihypertensive combination was Angiotensin Receptor Blocker and Calcium Channel Blocker (30.10%). There was a significant relationship between age, comorbidities, duration of hypertension, and antihypertensive drug regimen on achieving blood pressure targets (p<0.05). The predictor factors that significantly influence achieving blood pressure targets in hypertensive patients are age, comorbidities, duration of hypertension, and antihypertensive therapy regiment